Published in Scand J Gastroenterol on October 01, 1990
Experimental pancreatic hyperplasia and neoplasia: effects of dietary and surgical manipulation. Br J Cancer (1993) 1.14
Pancreatic hypertrophy with acinar cell nodules after longterm fundectomy in the rat. Gut (1993) 0.84
Profound duodenogastric reflux causes pancreatic growth in rats. Gut (1995) 0.76
Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg (2001) 2.94
Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology (1986) 2.46
Localization of vasoactive intestinal polypeptide (VIP) to central and peripheral neurons. Proc Natl Acad Sci U S A (1976) 2.45
Production and evaluation of antibodies for the radioimmunoassay of gastrin. Scand J Clin Lab Invest (1972) 2.39
Molecular cloning of human gastrin cDNA: evidence for evolution of gastrin by gene duplication. Proc Natl Acad Sci U S A (1983) 2.35
Neuropeptide Y co-exists and co-operates with noradrenaline in perivascular nerve fibers. Regul Pept (1984) 2.27
Determination of gastrin in serum. An evaluation of the reliability of a radioimmunoassay. Scand J Gastroenterol (1973) 2.12
Total pancreatectomy for cancer. An appraisal of 65 cases. Ann Surg (1977) 2.08
Preparation of 125 I-labelled synthetic human gastrin I for radioimmunoanalysis. Scand J Clin Lab Invest (1972) 2.07
Evidence for different pre-and post-junctional receptors for neuropeptide Y and related peptides. Regul Pept (1986) 2.05
[Molecular biology]. Ugeskr Laeger (2000) 2.02
[Back pain--time for a little science?]. Ugeskr Laeger (1998) 2.02
Immunochemical studies on cholecystokinin. II. Distribution and molecular heterogeneity in the central nervous system and small intestine of man and hog. J Biol Chem (1978) 1.99
Gel filtration studies on immunoreactive gastrin in serum from Zollinger-Ellison patients. Gut (1973) 1.97
Endocrine cells in human intestine: an immunocytochemical study. Gastroenterology (1983) 1.90
Pancreatic somatostatinoma. Clinical features and physiological implications. Lancet (1977) 1.81
Ghrelin stimulates gastric emptying and hunger in normal-weight humans. J Clin Endocrinol Metab (2006) 1.81
Increased cardiac BNP expression associated with myocardial ischemia. FASEB J (2003) 1.78
Gefitinib in patients with chemo-sensitive and chemo-refractory relapsed small cell cancers: a Hoosier Oncology Group phase II trial. Lung Cancer (2006) 1.77
A specific substance P antagonist blocks smooth muscle contractions induced by non-cholinergic, non-adrenergic nerve stimulation. Nature (1981) 1.76
Pancreatic polypeptide - a postulated new hormone: identification of its cellular storage site by light and electron microscopic immunocytochemistry. Diabetologia (1976) 1.74
Localization of substance P-like immunoreactivity in mouse gut. Histochemistry (1975) 1.71
Somatostatin cell processes as pathways for paracrine secretion. Science (1979) 1.69
Immunoreactive gastrin components in human serum. Gut (1974) 1.65
Vagal, cholinergic regulation of pancreatic polypeptide secretion. J Clin Invest (1978) 1.63
Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer. Br J Surg (1993) 1.62
Immunochemical studies on cholecystokinin. I. Development of sequence-specific radioimmunoassays for porcine triacontatriapeptide cholecystokinin. J Biol Chem (1978) 1.62
Histamine in endocrine cells in the stomach. A survey of several species using a panel of histamine antibodies. Histochemistry (1986) 1.57
Pancreatic cancer is associated with impaired glucose metabolism. Eur J Surg (1993) 1.57
Pancreatic-polypeptide response to food in duodenal-ulcer patients before and after vagotomy. Lancet (1976) 1.56
Occurrence and distribution of VIP nerves in the nasal mucosa and tracheobronchial wall. Acta Otolaryngol (1979) 1.54
Evaluation of aggressive surgery for carcinoma of the extrahepatic bile ducts. Ann Surg (1980) 1.54
The N34S mutation of SPINK1 (PSTI) is associated with a familial pattern of idiopathic chronic pancreatitis but does not cause the disease. Gut (2002) 1.50
Localization and molecular heterogeneity of cholecystokinin in the central and peripheral nervous system. Brain Res (1979) 1.49
Effect of endoscopic sphincterotomy and interval cholecystectomy on late outcome after gallstone pancreatitis. Br J Surg (1998) 1.47
Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vessels. Br J Pharmacol (1984) 1.46
Recurrence of exocrine pancreatic cancer--local or hepatic? Hepatogastroenterology (1993) 1.45
Endogenous hypergastrinaemia does not promote growth of colonic mucosa or of a transplanted colon adenocarcinoma in rats. Eur J Gastroenterol Hepatol (1998) 1.42
Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects. Obes Surg (2012) 1.42
Mixed endocrine pancreatic tumors producing several peptide hormones. Am J Pathol (1975) 1.41
Biological evaluation of substance P antagonists. Br J Pharmacol (1984) 1.39
S-enantiomer of the selective serotonin reuptake inhibitor citalopram compared with racemate citalopram (S+R). Pharmacol Toxicol (2001) 1.39
Neuropeptides and neural cell adhesion molecule (NCAM) in CSF from patients with ALS. Acta Neurol Scand (1989) 1.39
Cloned cell lines from a transplantable islet cell tumor are heterogeneous and express cholecystokinin in addition to islet hormones. J Cell Biol (1986) 1.39
[On back training in low back pain]. Ugeskr Laeger (1993) 1.39
[New methods for cancer classification. Current light microscopy can and should be added]. Lakartidningen (1997) 1.38
Expression but incomplete maturation of progastrin in colorectal carcinomas. Gastroenterology (1993) 1.37
Abnormal gastric histology and decreased acid production in cholecystokinin-B/gastrin receptor-deficient mice. Gastroenterology (1997) 1.37
Pain reduction by an oral pancreatic enzyme preparation in chronic pancreatitis. Dig Dis Sci (1983) 1.36
Release of gastrin by epinephrine in man. Gastroenterology (1973) 1.35
The role of endogenous gastrin in the activation of gastric histidine decarboxylase in the rat. Effect of antrectomy and vagal denervation. Eur J Pharmacol (1970) 1.34
Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action. J Pharmacol Exp Ther (1985) 1.34
Impaired gastric acid secretion in gastrin-deficient mice. Am J Physiol (1998) 1.33
Multiple tachykinin pools in sensory nerve fibres in the rabbit iris. Neuroscience (1987) 1.32
Peptidergic (substance P) nerves in the genito-urinary tract. Neuroscience (1978) 1.31
Cellular localization of histamine and monoamines in the gastric mucosa of man. Histochemie (1969) 1.30
Peptidergic (enkephalin) innervation of the mammalian esophagus. Gastroenterology (1980) 1.27
Immunohistochemical localization of a vasodilatory polypeptide (VIP) in cerebrovascular nerves. Brain Res (1976) 1.27
Factors influencing survival after total pancreatectomy in patients with pancreatic cancer. Ann Surg (1983) 1.27
Correlation between serum gastrin concentration and rat stomach histidine decarboxylase activity. J Physiol (1974) 1.27
Fluorometric determination of histamine with OPT: optimum reaction conditions and tests of identity. Anal Biochem (1972) 1.27
Distribution and properties of glucagon immunoreactivity in the digestive tract of various mammals: an immunohistochemical and immunochemical study. Histochemistry (1975) 1.27
A-like cells in the rat stomach contain ghrelin and do not operate under gastrin control. Regul Pept (2001) 1.26
Coexistence of peptide YY and glicentin immunoreactivity in endocrine cells of the gut. Regul Pept (1984) 1.26
The effect of neuropeptide Y and peptide YY on electrogenic ion transport in rat intestinal epithelia. J Physiol (1988) 1.25
Lack of vasoactive intestinal polypeptide nerves in esophageal achalasia. Gastroenterology (1983) 1.25
Evidence for coexistence of dopamine and CCK in meso-limbic neurones. Nature (1980) 1.24
Structure of a human gastrin gene. Proc Natl Acad Sci U S A (1984) 1.23
Gastrin stimulates the self-replication rate of enterochromaffinlike cells in the rat stomach. Effects of omeprazole, ranitidine, and gastrin-17 in intact and antrectomized rats. Gastroenterology (1990) 1.23
Peptide-containing nerve fibers in the stomach wall of rat and mouse. Gastroenterology (1985) 1.23
New consensus features for tyrosine O-sulfation determined by mutational analysis. J Biol Chem (1997) 1.23
Calcitonin gene-related peptide (CGRP): perivascular distribution and vasodilatory effects. Regul Pept (1986) 1.22
Concomitant histochemical demonstration of histamine and catecholamines in enterochromaffin-like cells of gastric mucosa. Life Sci (1967) 1.22
Intestinal obstruction with strangulation of the small bowel. Acta Chir Scand (1987) 1.21
Distribution, ontogeny and ultrastructure of somatostatin immunoreactive cells in the pancreas and gut. Cell Tissue Res (1977) 1.20
Suppression of rat stomach histidine decarboxylase activity by histamine: H2-receptor-mediated feed-back. J Physiol (1977) 1.20
A substance P antagonist, [D-Pro2, D-Trp7,9]SP, inhibits inflammatory responses in the rabbit eye. Science (1981) 1.20
Duodenal endocrine cells in adult coeliac disease. Gut (1979) 1.19
Localisation of gastrins to neuro- and adenohypophysis. Nature (1978) 1.19
Galanin: neuromodulatory and direct contractile effects on smooth muscle preparations. Br J Pharmacol (1985) 1.19
Percutaneous cytodiagnosis of carcinoma of the pancreas and bile duct. Ann Surg (1978) 1.19
Distribution, pathways and reactions to drug treatment of nerves with neuropeptide Y- and pancreatic polypeptide-like immunoreactivity in the guinea-pig digestive tract. Cell Tissue Res (1983) 1.18
Immunoreactive pancreatic polypeptide (PP) occurs in the central and peripheral nervous system: preliminary immunocytochemical observations. Cell Tissue Res (1979) 1.18
Improved fluorometric assay of histamine: condensation with O-phthalaldehyde at -20 degrees C. Anal Biochem (1974) 1.18
Increased incidence of pancreatic neoplasia in pernicious anemia. World J Surg (1988) 1.18
Nerve fibers in the gut and pancreas of the rat displaying neuropeptide-Y immunoreactivity. Intrinsic and extrinsic origin. Cell Tissue Res (1983) 1.17
Immunohistochemical localization of human pancreatic polypeptide (HPP) to a population of islet cells. Cell Tissue Res (1975) 1.16
The effect of gastrin on basal- and glucose-stimulated insulin secretion in man. J Clin Invest (1973) 1.16
Projections of peptide-containing neurons in rat small intestine. Neuroscience (1987) 1.16
Proliferation of enterochromaffinlike cells in omeprazole-treated hypergastrinemic rats. Gastroenterology (1989) 1.16
Projections of peptide-containing neurons in rat colon. Neuroscience (1988) 1.16
Gastrins in tissue. Concentration and component pattern in gastric, duodenal, and jejunal mucosa of normal human subjects and patients with duodenal ulcer. Gastroenterology (1976) 1.15
Control of gastric acid secretion:the gastrin-ECL cell-parietal cell axis. Comp Biochem Physiol A Mol Integr Physiol (2001) 1.15
Galanin nerve fibers in the rat gut: distribution, origin and projections. Neuroscience (1985) 1.15